Latest in News & Research
Cutaneous Immune-Related AEs Linked to Survival After ICI Therapy
Improved survival associated with cirAEs for patients receiving anti-programmed cell death 1 or anti-programmed cell death ligand 1 therapy
Depression Up in Pediatric, Adult Hidradenitis Suppurativa Patients
Prevalence of depression increased among adults and children with hidradenitis suppurativa
Pfizer Says Omicron-Specific Vaccine Ready by March
Pfizer also working to improve its current COVID-19 vaccine 'to address any future variant of potential concern, if needed'
Severe COVID-19 Outcomes Rare After Primary Vaccination
Risk higher for people who were aged 65 years or older, immunosuppressed, or had at least one of six underlying conditions
Relatlimab-Nivolumab Ups PFS in Untreated Advanced Melanoma
Combination provides greater benefit than nivolumab alone for progression-free survival in untreated metastatic or unresectable melanoma
Secukinumab Beneficial for Psoriatic Arthritis, Concomitant Plaque Psoriasis
Significantly more patients receiving secukinumab versus adalimumab achieved PASI 100 response at week 52
How Satisfied Are Patients With Clinic-Based Hidradenitis Suppurativa Surgery?
Despite recurrence, most patients with hidradenitis suppurativa are very satisfied with their surgical results
Antibiotic Choices for Skin, Soft Tissue Infections Vary by Race
Compared with White inpatients, Black inpatients less likely to receive cefazolin, more likely to receive clindamycin for SSTIs
Serious Adverse Effects From COVID-19 Vaccines Reported Rarely
Full vaccination dose, younger age, female sex, and previously having had COVID-19 linked to greater odds of adverse effects
Atopic Dermatitis Exacerbations Seen in Premenstrual Period
Worsening reported in eczema area and severity index score, numerical rating scale worst itch, and dermatology life quality index
Scientists Spot Clues to Why Omicron Infections Are Milder
More than a dozen research groups have been observing the omicron variant in lab settings using animals this past month
Is Ultrasonography More Sensitive for Detecting Metastases in High-Risk SCC?
Baseline ultrasonography more sensitive for detecting lymph node metastases than clinical examination alone
Is Apremilast Efficacious, Safe for Mild-to-Moderate Psoriasis?
Significantly greater response rate seen in static Physician Global Assessment at week 16 for apremilast versus placebo
High-Fiber Diet May Benefit Melanoma Patients on Immunotherapy
Higher intake of dietary fiber linked to longer progression-free survival in melanoma patients on immune checkpoint blockade
Spesolimab Clears Lesions in Generalized Pustular Psoriasis
In phase 2 trial, spesolimab cleared more lesions than placebo, but it was associated with infections, systemic drug reactions
AI Allows Automated Scoring of Psoriasis Area, Severity
Conventional neural networks have the potential to automatically perform image-based Psoriasis Area and Severity Index scoring
Botox Injections Linked to Lower Incidence of Anxiety Symptoms
Protective effect of BoNT found for different indications, including in cosmetic use/facial muscles, migraine/facial and head muscles
Are Novel Inflammatory Markers Prognostic for Mortality in Epidermal Necrolysis?
Red cell distribution width to hemoglobin ratio shows similar predictive ability to SCORTEN; better discrimination with composite
What Factors Impact Treatment Outcomes in Psoriasis?
Patients on TNFi or IL-17i have lower odds of achieving treatment outcomes with comorbid obesity and history of diabetes
Serum Biomarkers Can Differentiate Psoriatic Arthritis, RA
Panel of serum protein biomarkers identified and evaluated for potential use in diagnostic testing for early-onset psoriatic arthritis
Freedom From Disease' in Psoriasis Is Multicomponent Concept
Definition includes five domains of management of clinical symptoms, psychosocial elements, QoL, treatment, health care team support
Does Dupilumab Provide Sustained Control of Atopic Dermatitis?
Dupilumab can help patients achieve adequate disease control and reduce use of other therapies
COVID-19 Severity Does Not Differ for Patients With Skin Conditions
Acute COVID-19 and its treatment can impact the course of skin disease in vitiligo, psoriasis, atopic dermatitis, chronic urticaria
24 of 1292